Pacific Biosciences of California (PACB) P/E (2011 - 2026)
Pacific Biosciences of California (PACB) P/E from Mar 31, 2011 to Jun 3, 2026. The TTM Pacific Biosciences of California (PACB) P/E is -3.71. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Pacific Biosciences of California (PACB)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.71 | +260.97% |
| 2025 | -1.03 | -36.14% |
| 2024 | -1.61 | -79.29% |
| 2023 | -7.77 | +26.85% |
| 2022 | -6.13 | -73.48% |
| 2021 | -23.10 | -110.38% |
| 2020 | 222.65 | -2483.74% |
| 2019 | -9.34 | -8.18% |
| 2018 | -10.17 | +235.61% |
| 2017 | -3.03 | -49.51% |
| 2016 | -6.00 | -80.64% |
| 2015 | -31.01 | +265.85% |
| 2014 | -8.48 | +123.33% |
| 2013 | -3.80 | +283.93% |
| 2012 | -0.99 | -43.17% |
| 2011 | -1.74 | N/A |
Comparison Pacific Biosciences of California (PACB) P/E with competitors
Pacific Biosciences of California (PACB) P/E is -3.71.